Doxorubicin and a butyric acid derivative effectively reduce levels of BCL-2 protein in the cells of chronic lymphocytic leukemia patient

E. Rabizadeh, O. Bairey, A. Aviram, I. Ben-Dror, M. Shaklai, Y. Zimra*

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Doxorubicin and a butyric acid derivative effectively reduce levels of BCL-2 protein in the cells of chronic lymphocytic leukemia patient'. Together they form a unique fingerprint.

Medicine & Life Sciences